This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Kabushiki Kaisha Yakult Honsha. Active years: 2013-2020.
Location History:
- Minato-ku, JP (2013)
- Saitama, JP (2020)
Company Filing History:
Years Active: 2013-2020
Title: The Innovative Contributions of Kaoru Moriyama in Equol Research
Introduction
Kaoru Moriyama, an accomplished inventor based in Saitama, Japan, has made significant strides in the field of microbiology with his innovative patented methods. His work primarily focuses on the production of equol, a compound noted for its beneficial properties in human health. With two patents to his name, Moriyama continues to influence research in this vital area.
Latest Patents
Moriyama's latest patents showcase his groundbreaking approaches in equol research. The first, titled "Method for measuring equol-producing ability," discloses an innovative method for determining whether a test subject possesses equol-producing ability. This method utilizes three specific primer sets to accurately detect the equol-converting enzyme gene derived from the subject's enteric bacteria.
His second patent, "Equol-producing bacterium and use thereof," is directed towards a unique microorganism capable of converting daidzein to equol in 24 hours at a rate of 50% or higher. This invention includes a food, beverage, or pharmaceutical composition containing the microorganism, a method for its equol production, and a nucleic acid fragment for its specific detection.
Career Highlights
Kaoru Moriyama currently works at Yakult Honsha Co., Ltd., a company renowned for its contributions to probiotics and nutritional products. His role at Yakult has placed him at the nexus of innovative research and practical application, allowing his inventions to have a real-world impact on health and wellness.
Collaborations
Throughout his career, Moriyama has collaborated with notable coworkers, such as Hirokazu Tsuji and Koji Nomoto. These partnerships have fostered a collaborative environment that encourages the sharing of ideas and expertise, enhancing the quality and scope of research conducted at Yakult.
Conclusion
In summary, Kaoru Moriyama is a significant figure in the field of microbiology, particularly for his methodologies concerning equol production. His innovative patents not only reflect his dedication to research but also promise to influence future developments in health and nutrition. As he continues to work with esteemed colleagues at Yakult Honsha, the potential for further groundbreaking discoveries remains vast.